Ovarian cancer has the unfortunate distinction of being the most deadly gynecological cancer known to conventional medical practice today, while also being one of the most frequently misdiagnosed conditions (i.e. ‘overdiagnosed’), with five times more women without ovarian cancer ending up having surgery than those with ovarian cancer. This is a devastating though largely unpublicized fact I discussed in greater depth in a recent article on GreenMedInfo.com: “Ovarian Cancer: What We Think We Know May Harm Us.”
Considering that the present day ‘standard of care’ within conventional medical practice for ovarian cancer is surgery, radiotherapy and chemotherapy – all of which have deadly side effects including, ironically, cancer and/or increased cancer invasiveness – shouldn’t safe and effective alternatives be given our full attention?
So what are these alternatives?
At GreenMedInfo.com we have indexed published research on over 30 natural substances with experimentally confirmed potential as anti-ovarian cancer agents, including common plant phytocompounds such as curcumin (turmeric), genistein (soy, kudzu, red clover), and resveratrol (grapes, red wine, peanuts). But the one substance that is taking on increased relevance in the fight against women-specific cancer is flaxseed, which has already been extensively shown by research to reduce breast cancer incidence, and even shows some direct anti-tumor properties.
The Medicinal Wonder of Flaxseed
A 2010 study published in the journal Gynecological Oncology found that hens fed with a 10% flaxseed-enriched diet for 1 year had “a significant reduction in late stage ovarian tumors”, as well as “overall better health and reduced mortality”.  The study authors concluded “These findings may provide the basis for a clinical trial that evaluates the efficacy of flaxseed as a chemo-suppressant of ovarian cancer in women”.
More recently, a study published this year in BMC Genomics looked deeper into the possible molecular mechanisms involved in flaxseed’s anti-tumor properties in ovarian cancers.  Researchers used a “bioinformatic” approach by analyzing the pattern of gene expression in ovarian tumors, identifying which genes are up-regulated when tumors form and which are suppressed when the hens are fed a 10% flaxseed diet.
Interestingly, they found that “a group of highly up-regulated genes that are involved in the embryonic process of branching morphogenesis [note: embryogenesis and carcinogenesis share similarities]” were reduced 40-60% in flaxseed fed hens. Moreover these ‘cancer associated’ changes in gene expression corresponded with increases in two specific cancer-associated biomolecules — E-cadherin and miR200 — both of which were decreased 60-75% in tumors from flax-fed hens.
The study authors concluded “that nutritional intervention with flaxseed targets the pathways regulating branching morphogenesis and thereby alters the progression of ovarian cancer”.
Obviously, this is only preliminary research, and since flaxseed has not gone through validation by the randomized, placebo-controlled, human trials required to receive the FDA drug approval needed for conventional oncologists to feel comfortable recommending it for prevention or treatment of ovarian cancer, you won’t hear anyone within the conventional medical establishment recommend or prescribe it.
But should that prevent us from using it?
As a food, flaxseed is exceptionally safe and affordable. This alone is reason enough to give it priority consideration when it comes to dietary and/or functional medical interventions for serious conditions that conventional medicine admits it has no effective solutions for.
Lastly, true prevention requires the avoidance of preventable causes of ovarian cancer which include chemicals and incompatible foods. GreenMedInfo’s ovarian cancer research page lists several known risk factors for ovarian cancer, e.g. cow’s milk, bisphenol A, acrylamide.
In short, often the ‘cure’ for cancer is to identify, remove and/or remedy the damage associated with the cause.
daily alternative | alternative news – Flaxseed: an Ovarian Cancer-Killer?
Google Now Has Access To Millions of Patients’ Medical Records
A controversial deal between tech giant Google and the National Health Service (NHS) will allow artificial intelligence units access to 1.6 million confidential medical records. Since 2014, Google has partnered with several scientists in an attempt to understand human health, but a new report reveals the data gathering goes far beyond what was originally anticipated.
According to documents obtained by the New Scientist, the data sharing agreement between Google-owned artificial intelligence company DeepMind and the Royal Free NHS Trust gives access to the sensitive healthcare data of millions of NHS patients. The chilling and wide-reaching deal allows DeepMind access to the medical records of the 1.6 million people passing annually through the three London hospitals owned by the Trust — Barnet, Chase Farm, and the Royal Free.
The Google-owned A.I. firm announced in February it was working with the NHS to build an app called Streams — intended to help hospitals monitor patients with kidney disease. However, the new information has revealed that the extent of the data being shared goes much further and includes logs of day-to-day hospital activity, records of the location and status of patients, and even logs of who visits them and when.
Results of pathology and radiology tests are also shared, as is information from critical care and accident and emergency departments. In addition, DeepMind’s access to the centralised records of all NHS hospital treatments in the U.K. means the tech company can access historical data from the last five years, all while receiving a continuous stream of new data.
At the same time, DeepMind is developing a platform called Patient Rescue, which uses hospital data streams to build tools to carry out analysis and support diagnostic decisions. The New Scientist explained how it works:
Comparing a new patient’s information with millions of other cases, Patient Rescue might be able to predict that they are in the early stages of a disease that has not yet become symptomatic, for example. Doctors could then run tests to see if the prediction is correct.
While the Royal Free has not yet responded to the question of what — if any — opt-out mechanisms are available to patients, the New Scientist suggests this is unlikely to be a straightforward process. Despite the agreement stating Google cannot use the data in any other part of the company’s business, many will be seriously wary of the access the online tech giant now has to the confidential data of millions of people.
As the New Scientist wrote:
Data mining is the name of the game in the burgeoning field of machine learning and artificial intelligence, and there’s no company in the world better at that than Google.
daily alternative | alternative news – Google Now Has Access To Millions of Patients’ Medical Records
Latest Crypto Price
|Quotes delayed up to 3 minutes.|
Wifi, Microwaves and the Consequences to our Health
Cell phones cause Cancer – Industry Cover Up
Data trails – Your data and who uses it
Enslavement – Then, Now and the Future
The Financial System Exposed
Follow us on Twitter
Law & Politics7 years ago
Did Tony Blair cover up paedophile scandal?
Videos2 months ago
Wifi, Microwaves and the Consequences to our Health
Breaking4 years ago
Putin: Western Governments Are Enslaving Humanity Through Vaccines
Technology4 years ago
Google Upgrades Digital Wallet to Pay by Facial Recognition